First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies.
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Animal embryotoxicity data, and the scarcity of safety data in human pregnancies, have prevented artemisinin derivatives from being recommended for malaria treatment in the first trimester except in lifesaving circumstances. We conducted a meta-analysis of prospective observational studies comparing the risk of miscarriage, stillbirth, and major congenital anomaly (primary outcomes) among first-trimester pregnancies treated with artemisinin derivatives versus quinine or no antimalarial treatment. METHODS AND FINDINGS: Electronic databases including Medline, Embase, and Malaria in Pregnancy Library were searched, and investigators contacted. Five studies involving 30,618 pregnancies were included; four from sub-Saharan Africa (n = 6,666 pregnancies, six sites) and one from Thailand (n = 23,952). Antimalarial exposures were ascertained by self-report or active detection and confirmed by prescriptions, clinic cards, and outpatient registers. Cox proportional hazards models, accounting for time under observation and gestational age at enrollment, were used to calculate hazard ratios. Individual participant data (IPD) meta-analysis was used to combine the African studies, and the results were then combined with those from Thailand using aggregated data meta-analysis with a random effects model. There was no difference in the risk of miscarriage associated with the use of artemisinins anytime during the first trimester (n = 37/671) compared with quinine (n = 96/945; adjusted hazard ratio [aHR] = 0.73 [95% CI 0.44, 1.21], I2 = 0%, p = 0.228), in the risk of stillbirth (artemisinins, n = 10/654; quinine, n = 11/615; aHR = 0.29 [95% CI 0.08-1.02], p = 0.053), or in the risk of miscarriage and stillbirth combined (pregnancy loss) (aHR = 0.58 [95% CI 0.36-1.02], p = 0.099). The corresponding risks of miscarriage, stillbirth, and pregnancy loss in a sensitivity analysis restricted to artemisinin exposures during the embryo sensitive period (6-12 wk gestation) were as follows: aHR = 1.04 (95% CI 0.54-2.01), I2 = 0%, p = 0.910; aHR = 0.73 (95% CI 0.26-2.06), p = 0.551; and aHR = 0.98 (95% CI 0.52-2.04), p = 0.603. The prevalence of major congenital anomalies was similar for first-trimester artemisinin (1.5% [95% CI 0.6%-3.5%]) and quinine exposures (1.2% [95% CI 0.6%-2.4%]). Key limitations of the study include the inability to control for confounding by indication in the African studies, the paucity of data on potential confounders, the limited statistical power to detect differences in congenital anomalies, and the lack of assessment of cardiovascular defects in newborns. CONCLUSIONS: Compared to quinine, artemisinin treatment in the first trimester was not associated with an increased risk of miscarriage or stillbirth. While the data are limited, they indicate no difference in the prevalence of major congenital anomalies between treatment groups. The benefits of 3-d artemisinin combination therapy regimens to treat malaria in early pregnancy are likely to outweigh the adverse outcomes of partially treated malaria, which can occur with oral quinine because of the known poor adherence to 7-d regimens. REVIEW REGISTRATION: PROSPERO CRD42015032371.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The cohort established significant evidence on treatment which informed WHO and changed its global malaria treatment guidelines to artemisinin-based combination therapies (ACTs). 29”
From Cohort Profile: the SMRU Refugee and Migrant Pregnancy Study in Western Thailand and Eastern Myanmar (2026) · cites this paper as [29]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ACTS are both more efficacious and safer than previously recommended treatments (like quinine).”
From Cohort Profile: the SMRU Refugee and Migrant Pregnancy Study in Western Thailand and Eastern Myanmar (2026) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stewart, L. A., Clarke, M., Rovers, M., Riley, R. D., Simmonds, M., Stewart, G., & Tierney, J. F. (2015) · JAMA · doi:10.1001/jama.2015.3656 · Cited by 2,134
Meta-analysis of individual participant data: rationale, conduct, and reporting
Riley, R. D., Lambert, P. C., & Abo-Zaid, G. (2010) · BMJ · doi:10.1136/bmj.c221 · Cited by 1,701 · cited 1×
“…in four independent prospective observational studies across six sites in sub-Saharan Africa using individual participant data (IPD) meta-analysis [26] and combined the results with summary effect estimates from the Shoklo Malaria Research Unit (SMRU) at the Thailand–Myanmar border, using…”
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432 · cited 3×
“Consistent with the known adverse effects of malaria in pregnancy [17,18,22,23], our results indicate that pregnancies treated with quinine in early pregnancy were associated with an increased risk of miscarriage compared to pregnancies not requiring treatment for malaria.”
Self-citationThe burden of malaria in pregnancy in malaria-endemic areas
Steketee, R., Nahlen, B., Parise, M., & Menendez, C. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.28 · Cited by 1,063
Self-citationQuinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J. K., Baliraine, F. N., Rosenthal, P. J., & D'Alessandro, U. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-144 · Cited by 1,007 · cited 2×
“Quinine has been used since the 17th century [40] and is thought to be safe in pregnancy although there have not been any formal studies in early pregnancy assessing its safety and efficacy [44].”
Self-citationAn analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed · Cited by 782
Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490 · cited 1×
“Despite the high burden of malaria in pregnancy, with an estimated 125 million at risk of infection annually in malaria endemic regions globally [49], fewer than 1,700 episodes of firstMeta-analysis of the safety of artemisinin and quinine in first trimester”
Self-citationClinical Epidemiology: How to Do Clinical Practice Research
Heneghan, C. (2006) · ACP Journal Club · doi:10.7326/acpjc-2006-145-1-a11 · Cited by 403
Clinical Epidemiology: How to Do Clinical Practice Research
Haynes, R. B., Sackett, D. L., Guyatt, G. H., & Tugwell, P. (2005) · Medical Entomology and Zoology · Cited by 361
The epidemiology of severe malaria in an area of low transmission in Thailand.
Luxemburger, C., Ricci, F., Nosten, F., Raimond, D., Bathet, S., & White, N. J. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90066-3 · Cited by 299
Self-citation
Research works printed but not linked: 1
- R Clark, 2006, Artesunate: developmental toxicity in monkeys, Birth Defects Res A Clin Mol Teratol, 76, 329
Cited by
Phillips, M. A., Burrows, J. N., Manyando, C., van Huijsduijnen, R. H., Van Voorhis, W. C., & Wells, T. N. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.50 · Cited by 649
“Of Oxford, UK) NMRC-M3V-Ad-Pf5 (NMRC) GMZ2 (EVI*, UKT, SSI, ASH, AMANET, NHRC, CNRFP, LSHTM, MUK and MRCG) MSP3 [181-276] (AMANET, EVI, CHUV, Bamako U.”
Self-citationAshley, E. A., Pyae Phyo, A., & Woodrow, C. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30324-6 · Cited by 553
Varo, R., Chaccour, C., & Bassat, Q. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.05.010 · Cited by 174
“41 Congenital malaria is rare in endemic countries where mothers have high level of antibodies which they transmit to their offspring, however this complication needs to be taken into consideration when naïve pregnant women with no immunity whatsoever against malaria travel to endemic areas and get…”
Plewes, K., Leopold, S. J., Kingston, H. W. F., & Dondorp, A. M. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2018.10.002 · Cited by 153
Saito, M., Briand, V., Min, A. M., & McGready, R. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30099-7 · Cited by 61
Self-citationAntimalarial drugs for treating and preventing malaria in pregnant and lactating women
Saito, M., Gilder, M. E., McGready, R. M., & Nosten, F. H. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1535593 · Cited by 58
“A recent meta-analysis assessed pregnancy outcomes of 717 pregnant women who were exposed to artemisinin derivatives in the first trimester [5].”
BackgroundMethodInfluentialSelf-citationManagement of malaria in pregnancy
Rogerson, S. J. (2017) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1304_17 · Cited by 75
Saito, M., McGready, R. M., Tinto, H., Rouamba, T., Mosha, D., Rulisa, S., Kariuki, S., Desai, M. R., Manyando, C., Njunju, E. M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01881-5 · Cited by 54
Self-citationTreatment of uncomplicated and severe malaria during pregnancy
D’Alessandro, U., Hill, J., Tärning, J., Pell, C. L., Webster, J., Gutman, J., & Sevene, E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30065-3 · Cited by 49
Self-citationDrug treatment and prevention of malaria in pregnancy: a critical review of the guidelines
Al Khaja, K. A. J., & Sequeira, R. P. (2021) · Malaria Journal · doi:10.1186/s12936-020-03565-2 · Cited by 39
Saito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30064-5 · Cited by 44
Self-citationWalker, P. G. T., Cairns, M. E., Slater, H., Gutman, J., Kayentao, K., Williams, J. E., Coulibaly, S. O., Khairallah, C., Taylor, S. M., Meshnick, S. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17528-3 · Cited by 42
Self-citationSaito, M., Gilder, M. E., Nosten, F. H., McGready, R. M., & Guerin, P. J. (2017) · Malaria Journal · doi:10.1186/s12936-017-2135-y · Cited by 35
Self-citationMehta, U. C., van Schalkwyk, C., Naidoo, P., Ramkissoon, A., Mhlongo, O., Maharaj, N. R., Naidoo, N., Fieggen, K. J., Urban, M. F., Krog, S., et al. (2019) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v20i1.971 · Cited by 33
Self-medication practice and contributing factors among pregnant women
Niriayo, Y. L., Mohammed, K., Asgedom, S. W., Demoz, G. T., Wahdey, S., & Gidey, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251725 · Cited by 47
Varo, R., Chaccour, C., & Bassat, Q. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.05.024 · Cited by 31
Malaria in pregnancy: adverse pregnancy outcomes and the future of prevention
Berhe, A. D., Doritchamou, J. Y. A., & Duffy, P. E. (2023) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2023.1229735 · Cited by 30
Nana, R. R. D., Hawadak, J., Foko, L. P. K., Kumar, A., Chaudhry, S., Arya, A., & Singh, V. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2128563 · Cited by 39
Saito, M., Gilder, M. E., Nosten, F. H., Guerin, P. J., & McGready, R. M. (2017) · Malaria Journal · doi:10.1186/s12936-017-2136-x · Cited by 29
Self-citationCalado, A. M., & Pires, M. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7883-0_1 · Cited by 58
Salih, A. M., Qahtan, A. A., & Al‐Qurainy, F. (2023) · Metabolites · doi:10.3390/metabo13030443 · Cited by 30
Saito, M., Carrara, V. I., Gilder, M. E., Min, A. M., Tun, N. W., Pimanpanarak, M., Viladpai-nguen, J., Paw, M. K., Haohankhunnatham, W., Konghahong, K., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02002-8 · Cited by 25
Self-citationRe-orienting anti-malarial drug development to better serve pregnant women
Gaaloul, M. E., Tornesi, B. M., Lebus, F., Reddy, D., & Kaszubska, W. (2022) · Malaria Journal · doi:10.1186/s12936-022-04137-2 · Cited by 24
“Although non-clinical data have raised concerns [22], a metaanalysis of prospective observational studies concluded that compared to quinine, artemisinin treatment (mainly artemether-lumefantrine, AL) in the first trimester is not associated with an increased risk of miscarriage or stillbirth [23].”
Saito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01592-z · Cited by 23
Self-citationEpelboin, L., Rapp, C., Faucher, J., Mechai, F., Bottieau, E., Matheron, S., Malvy, D. J.-M., & Caumes, É. (2019) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2019.07.011 · Cited by 21
Ballard, S.-B., Salinger, A., MPHc, Arguin, P. M., Desai, M., & Tan, K. R. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6714a4 · Cited by 24
Self-citationSaito, M., Mansoor, R., Kennon, K., McGready, R. M., Nosten, F. H., Guerin, P. J., & Stepniewska, K. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027503 · Cited by 18
Self-citationTesema, G. A., Teshale, A. B., Yeshaw, Y., Angaw, D. A., & Lakew, A. M. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-062149 · Cited by 19
Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
McGready, R. M., Nosten, F. H., Barnes, K. I., Mokuolu, O. A., & White, N. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30161-6 · Cited by 17
Self-citationGonzález, R., Pons‐Duran, C., Bardají, A., Leke, R. G. F., Clark, R. L., & Menéndez, C. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115127 · Cited by 17
Self-citationSafety of Artemisinin Derivatives in the First Trimester of Pregnancy: A Controversial Story
D’Alessandro, S., Menegola, E., Parapini, S., Taramelli, D., & Basilico, N. (2020) · Molecules · doi:10.3390/molecules25153505 · Cited by 19
“The authors analysed the results of sixteen studies on ACT safety in the second and third trimester, whereas for the first trimester they only considered the meta-analysis by Dellicour and colleagues that is described above [15].”
BackgroundResultHill, J., Landuwulang, C. U. R., Ansariadi, A., Hoyt, J., Burdam, F. H., Bonsapia, I., Syafruddin, D., Poespoprodjo, J. R., ter Kuile, F. O., Ahmed, R., et al. (2018) · Malaria Journal · doi:10.1186/s12936-018-2426-y · Cited by 19
Samuels, A. M., Towett, O., Seda, B., Wiegand, R. E., Otieno, K., Chomba, M., Lucchi, N. W., Ljolje, D., Schneider, K., Walker, P. G. T., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac289 · Cited by 16
Ukpai, O. M., Ijioma, S. N., Kanu, K. C., Orieke, D., Chinedu-Ndukwe, P. A., Ugwuanyi, K. C., & Ugbogu, E. A. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117170 · Cited by 17
Leke, A. Z., Malherbe, H. L., Kalk, E., Mehta, U., Kisa, P., Botto, L. D., Ayede, I. A., Fairlie, L., Maboh, M. N., Orioli, I. M., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001850 · Cited by 21
“The two main categories of risk factors investigated were medication safety in pregnancy (n = 8, [70,96,99,100,123,159,164,207]), and environmental pollution (n = 6).”
BackgroundFactors associated with short birth interval among reproductive-age women in East Africa
Tesema, G. A., Wolde, M., Tamirat, K. S., Worku, M. G., Fente, B. M., Tsega, S. S., Tadesse, A., & Teshale, A. B. (2023) · Women s Health · doi:10.1177/17455057231209879 · Cited by 16
Augusto, O. J., Stergachis, A. S., Dellicour, S., Tinto, H., Valá, A., Rupérez, M., Macete, E., Diallo, S. N., Kazienga, A., Valéa, I., et al. (2020) · Malaria Journal · doi:10.1186/s12936-020-03210-y · Cited by 14
Self-citationClark, R. L. (2017) · Birth Defects Research · doi:10.1002/bdr2.1035 · Cited by 15
“For example, Dellicour et al., 2017, conducted a meta-analysis of studies that were conducted in Africa and along the Thailand-Myanmar border and estimated that “A sample size calculation suggested that 1180 exposed cases (with a ratio of 1:4 unexposed and background rate of 0.9”
BackgroundMethodInfluentialDjimdé, M., Tshiongo, J. K., Mavoko, H. M., Tinto, H., Sevene, E., Traoré‐Coulibaly, M., Valá, A., Macuácua, S., Kaboré, B., Dabira, E. D., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-065295 · Cited by 11
Self-citationTeratogen update: Malaria in pregnancy and the use of antimalarial drugs in the first trimester
Clark, R. L. (2020) · Birth Defects Research · doi:10.1002/bdr2.1798 · Cited by 12
“No analysis of heterogeneity across the 7-day artesunate/3-day ACT treatment groups was reported as part of the metaanalysis (Dellicour et al., 2017).”
BackgroundMethodResultInfluentialOtieno, N. A., Nyawanda, B. O., Otiato, F., Oneko, M., Amin, M. M., Otieno, M. O., Omollo, D. O., McMorrow, M., Chaves, S. S., Dollard, S. C., et al. (2019) · Journal of Clinical Virology · doi:10.1016/j.jcv.2019.09.007 · Cited by 10
Self-citationBarrow, P. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.06.012 · Cited by 9
Clark, R. L. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.05.016 · Cited by 10
McGready, R., Paw, M. K., Wiladphaingern, J., Min, A. M., Carrara, V. I., Moore, K. A., Pukrittayakamee, S., & Nosten, F. H. (2018) · Wellcome Open Research · doi:10.12688/wellcomeopenres.10352.2 · Cited by 18
“Number of ANC visits, median{25th-75th percentile}, [min-max] 6 {3-11}, [1-22]”
Self-citationWu, D., Zeng, H., Tan, J., Xu, Q., Khan, F. A., Pandupuspitasari, N. S., Yang, S., & Huang, C. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s545163 · Cited by 10
“228,229 Evidence from non-clinic studies suggests that single or consecutive treatment of ARTs in the first trimester of pregnancy is associated with embryoleth - ality, due to the loss of circulating embryonic primitive erythroblasts, and teratogenic effects.”
Gutman, J., & Chico, R. M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30131-6 · Cited by 8
Updating an Overview of Teratology
Calado, A. M., Seixas, F., & Pires, M. A. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3625-1_1 · Cited by 8
Updated pharmacokinetic considerations for the use of antimalarial drugs in pregnant women
Moore, B. R., & Davis, T. M. E. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1802425 · Cited by 7
Koladjo, F., Yovo, E., Accrombessi, M., Agbota, G., Atade, W., Ladikpo, O. T., Mehoba, M., Degbe, A., Jackson, N., Massougbodji, A., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac012 · Cited by 7
“[37], there is increasing evidence of the efficacy [38] and safety [9][39] of artemisinin-based combinations in pregnant women in the 1 st trimester of pregnancy, reinforcing the idea of their use as first-line treatment for malaria [40][41].”
BackgroundPrüst, J. T., Brummaier, T., Wah, M., Yee, H. H., Win, N. N., Pimanpanarak, M., Min, A. M., Gilder, M. E., Tun, N. W., Ilozumba, O., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.17743.1 · Cited by 8
Self-citationTassew, W. C., Ferede, Y. A., Woldie, S. S., Yirdaw, B. W., Hussien, H. F., Yimer, B. B., Hailemariam, D. G., Mengistu, B. A., & Zeleke, A. M. (2023) · SAGE Open Medicine · doi:10.1177/20503121231194429 · Cited by 5
“24 In this analysis, the pooled estimate of two studies showed that pregnant women who experienced health problems during pregnancies at the moment were 5.7 times more likely to use self-medication compared to their current counterparts (OR: 5.7, 95% CI: 3.92–8.29).”
BackgroundMethodInfluentialSevere Case of Plasmodium falciparum Malaria in a Pregnant Woman from Nigeria
Yagnik, K. J., Farooqi, B., Mandernach, M. W., Cannella, A. P., & Kalyatanda, G. (2019) · Case Reports in Infectious Diseases · doi:10.1155/2019/2630825 · Cited by 5
“A review on the treatment of severe malaria in all trimesters of pregnancy supports the WHO recommendation for intravenous artesunate as the drug of choice [7].”
MethodWebster, J., Hoyt, J., Diarra, S., Manda‐Taylor, L., Okoth, G., Achan, J., Ghilardi, L., D’Alessandro, U., Madanista, M., Kariuki, S., et al. (2020) · Health Policy and Planning · doi:10.1093/heapol/czaa132 · Cited by 5
“In 2015, a meta-analysis of observational studies on the risk of adverse pregnancy outcomes associated with first-trimester treat-ment with artemisinin derivatives and quinine (Dellicour et al. , 2017) was presented to a WHO-ERG (WHO, 2015).”
BackgroundSelf-citationKong, X.-J., Liu, K.-M., Zuo, H.-L., Huang, H.-D., & Hu, Y.-J. (2022) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x22500306 · Cited by 4
Rao, B., Jensen, T. Ø., Jiménez, B. C., Robays, J., Lasry, E., Sterk, E., & Smet, M. D. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30228-6 · Cited by 6
Current Antimalarial Treatments: Focus on Artemisia annua Dry Leaf
Goel, R. (2022) · Infectious diseases · doi:10.5772/intechopen.106736 · Cited by 3
Borrallo-Lopez, L., Guzman, L., Romero, N. G., Sampietro, A., Mallo‐Abreu, A., Guardia-Escote, L., Teixidó, E., Flick, B., Fernàndez‐Busquets, X., Muñoz‐Torrero, D., et al. (2025) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2025.100582 · Cited by 2
“…of therapeutic doses of some ACTs during the first trimester of pregnancy was not associated with increased risk of miscarriage, stillbirth or congenital malformation, nor low birth weight by the available data in the given studies [D ’ Alessandro et al., 2020; Dellicour et al., 2017].”
Travel-Related Infections Among Pregnant Travellers to the Tropics: An Overview
Kong, L. Y., Libman, M., & Yansouni, C. P. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.08.006 · Cited by 2
Research in Pregnancy: Frameworks for Addressing a Neglected and Complex Study Population
Little, M. O., Wickremsinhe, M., & Lyerly, A. D. (2022) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190947750.013.49 · Cited by 2
Cohort Profile: the SMRU Refugee and Migrant Pregnancy Study in Western Thailand and Eastern Myanmar
McGready, R., J White, N., Nosten, F. H., & Collaborators, S. R. A. M. P. S. (2026) · Wellcome Open Research · doi:10.12688/wellcomeopenres.25582.2 · Cited by 2
Self-citationMalaria – Current Treatment Options
Virginia, D. M., Shegokar, R., & Pathak, Y. (2023) · Malarial Drug Delivery Systems · doi:10.1007/978-3-031-15848-3_4 · Cited by 1
Wang, W., Ge, L., Xiong, Y., Chen, J., Chen, C., Ren, Y., Thabane, L., Sun, X., & Tan, J. (2026) · Systematic Reviews · doi:10.1186/s13643-026-03235-5 · Cited by 1
“Numerous SRs focusing on specific anti-infectives or outcomes have been published [13, 14, 28], often with substantial topical overlap [29, 30].”
Gyebuni, P., Salifu, Y., & Lasong, J. (2025) · Malaria Journal · doi:10.1186/s12936-025-05342-5 · Cited by 1
“[25] also supports the assertions by Kovacs e t al.”
Kamegai, K., Hayakawa, K., Yamamoto, K., Nomoto, H., Komaki‐Yasuda, K., Kano, S., & Ohmagari, N. (2023) · Tropical Medicine and Health · doi:10.1186/s41182-023-00510-2 · Cited by 1
Pibini, A. G., Chiegil, S. J. D., Umeh, M. O., Nimiruna, I., Danladi, U., Hamza, A., Sani, R. A., & Stephen Maisamari, B. (2023) · Student s Journal of Health Research Africa · doi:10.51168/sjhrafrica.v4i6.472
Willey, C. J., & Calip, G. S. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.11.004 · Cited by 1
Self-citationKiller of Generations: Malaria Combat and Challenges
Kaushik, M., & Chahar, P. (2019) · South Asian Research Journal of Biology and Applied Biosciences · doi:10.36346/sarjbab.2019.v01i03.005
“In comparison to quinine, pregnant women with severe malaria in any trimester can be efficiently treated with artimisinin derivatives [35].”
BackgroundÜberlegenheit von Artemisininkombinationen über Chinin in allen Trimestern
Früh, J. (2020) · Flugmedizin · Tropenmedizin · Reisemedizin - FTR · doi:10.1055/a-1258-1434
Govindan, V. P., & Purushothama, K. M. (2022) · Infectious Disorders - Drug Targets · doi:10.2174/1871526522666220110163945
Maternal Malaria, Dengue, and Chikungunya
Rohatgi, A., & Grover, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7865-3_17 · Cited by 1
Treatment of Uncomplicated Malaria
Varo, R., & Bassat, Q. (2019) · Springer eBooks · doi:10.1007/978-1-4614-8326-7_150
Malaria in Pregnancy: Key Points for the Neonatologist
Rent, S. M., Bauserman, M., Laktabai, J., Tshefu, A. K., & Taylor, S. M. (2023) · NeoReviews · doi:10.1542/neo.24-9-e539 · Cited by 1
Staedke, S. G., Mpimbaza, A., Nankabirwa, J. I., & Kakuru, A. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009052733.021
Saito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408371
Self-citationAugusto, O. J., Stergachis, A., Dellicour, S., Tinto, H., Valá, A., Ruperez, M., Macete, E., Diallo, S. N., Kazienga, A., Valéa, I., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12101658
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408395
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408407
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408404
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408386
Self-citationSaito, M., Carrara, V. I., Gilder, M. E., Min, A. M., Tun, N. W., Pimanpanarak, M., Viladpai-nguen, J., Paw, M. K., Haohankhunnatham, W., Konghahong, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14759838
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408374
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408401
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408398
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408389
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408377
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408392
Self-citationSaito, M., Mansoor, R., Kennon, K., Anvikar, A. R., Ashley, E. A., Chandramohan, D., Cohee, L. M., D’Alessandro, U., Genton, B., Gilder, M. E., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12408380
Self-citationHoyt, J., Compaoré, A., Diarra, S., Bolombo, F. B., Nayiga, S., Zango, S. H., Djimdé, M., Dellicour, S., Tshiongo, J. K., Mavoko, H. M., et al. (2026) · International Journal of Qualitative Methods · doi:10.1177/16094069261449007
Self-citationKim, W., Cho, G., Gado, A., Baeurle, T. H. H., Karimi, H., Venezia, F., Oeuvray, C., Spangenberg, T., Wicha, S. G., & Demarta‐Gatsi, C. (2026) · Birth Defects Research · doi:10.1002/bdr2.70105
“However, recent clinical evidence has prompted WHO to endorse artemisinin-based combination therapies (ACTs), particularly artemether-lumefantrine (Coartem), as safe and effective for treating uncomplicated P. falciparum malaria across all trimesters of pregnancy (Dellicour et al. 2017).”
Metadata
- Authors
- Dellicour, S., Sevene, E., McGready, R., Tinto, H., Mosha, D., Manyando, C., Rulisa, S., Desai, M., Ouma, P., Oneko, M., Vala, A., Rupérez, M., Macete, E., Menéndez, C., Nakanabo-Diallo, S., Kazienga, A., Valéa, I., Calip, G., Augusto, O., Genton, B., Njunju, E. M., Moore, K. A., d’Alessandro, U., Nosten, F., ter Kuile, F., & Stergachis, A.
- Affiliations
- University of Liverpool (GB)
- Eduardo Mondlane University (MZ)
- Mahidol University (TH)
- Centre Muraz (BF)
- Ifakara Health Institute (TZ)
- Tropical Diseases Research Centre (ZM)
- University of Rwanda (RW)
- Centers for Disease Control and Prevention (US)
- Kenya Medical Research Institute (KE)
- Manhiça Health Research Centre (MZ)
- University of Illinois Chicago (US)
- Swiss Tropical and Public Health Institute (CH)
- Copperbelt University (ZM)
- Burnet Institute (AU)
- London School of Hygiene & Tropical Medicine (GB)
- University of Washington (US)
- Corresponding author
- Dellicour, Stephanie
- Stergachis, Andy
- ORCID
- Dellicour, Stephanie
- Sevene, Esperança
- McGready, Rose
- Tinto, Halidou
- Mosha, Dominic
- Manyando, Christine
- Rulisa, Stephen
- Desai, Meghna
- Oneko, Martina
- Macete, Eusébio
- Menéndez, Clara
- Nakanabo-Diallo, Seydou
- Kazienga, Adama
- Valéa, Innocent
- Calip, Gregory
- Augusto, Orvalho
- Genton, Blaise
- Moore, Kerryn A.
- d’Alessandro, Umberto
- Nosten, Francois
- Stergachis, Andy
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-05-02
- Volume
- 14
- Issue
- 5
- Pages
- e1002290
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5412992
- OpenAlex
- W2610284326
- Semantic Scholar
- 92e4596686fa9355db40b83f936b6ca0383e4ca0
- Cited by
- 90
- References
- 49
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 1 · 2023: 12 · 2022: 13 · 2021: 4 · 2020: 29 · 2019: 9 · 2018: 9 · 2017: 5
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Medicine (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
- IHI Repository (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- IRIS (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- edoc (University of Basel) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation (Malaria in Pregnancy Consortium)
- Wellcome Trust (Shoklo Malaria Research Unit)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- artemisinin derivatives, quinine, malaria in pregnancy, first trimester, miscarriage, stillbirth, major congenital malformations, antimalarial drug safety, sub-Saharan Africa, Thailand, drug safety in pregnancy
- MeSH terms
- Abnormalities, Drug-Induced, Abortion, Spontaneous, Asia, Southeastern, Female, Humans, Pregnancy, Pregnancy Trimester, First, Quinine, Prevalence, Africa South of the Sahara, Risk Assessment, Artemisinins, Stillbirth, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.